Medpace Holdings, Inc. to Present at Jefferies 2019 Healthcare Conference

CINCINNATI–(BUSINESS WIRE)–Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced
that it will present at the following investor conference in June:

Jefferies 2019 Healthcare Conference
Location:
New York, NY
Date: Tuesday, June 4, 2019
Presentation: 8:30
a.m. ET
Speakers: August Troendle, President & Chief Executive
Officer, and Jesse Geiger, Chief Financial Officer & Chief Operating
Officer, Laboratory Operations

A live webcast of each presentation will be accessible through the
“Investors” section of the Company’s website at www.medpace.com
and will be available for replay following each event.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical
contract research organization (CRO) providing Phase I-IV clinical
development services to the biotechnology, pharmaceutical, and medical
device industries. Medpace’s mission is to accelerate the global
development of safe and effective medical therapeutics through its
high-science and disciplined operating approach that leverages
regulatory and therapeutic expertise across all major areas including
oncology, cardiology, metabolic disease, endocrinology, central nervous
system, and anti-viral and anti-infective. Headquartered in Cincinnati,
Ohio, Medpace employs approximately 3,100 people across 36 countries.

Contacts

Media Contact:
Julie Hopkins
Medpace Holdings, Inc.
513.579.9911
x12627
[email protected]

Investor Contact:
[email protected]